Lexicon Pharmaceuticals, Inc. (LXRX) - Financial and Strategic SWOT Analysis Review

Date: May 24, 2016
Pages: 49
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: L7BC74E1431EN
Leaflet:

Download PDF Leaflet

Lexicon Pharmaceuticals, Inc. (LXRX) - Financial and Strategic SWOT Analysis Review
Lexicon Pharmaceuticals, Inc. (LXRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Lexicon Pharmaceuticals, Inc. (Lexicon) is a biopharmaceutical company, which focuses on the discovery and development of advanced treatments for human diseases. It has advanced multiple drug candidates into clinical development. The company has clinical-stage drug programs for type 1 and type 2 diabetes and carcinoid syndrome. Lexicon’s clinical and preclinical development programs are focused at treating irritable bowel syndrome (IBS), autoimmune diseases, glaucoma and diabetes. The company applies its proprietary gene knockout technology for discovery of physiological and behavioral functions. It has strategic collaborations with pharmaceutical and biotechnology companies. Lexicon has laboratories near Princeton, New Jersey and is headquartered in The Woodlands, Texas, the US.

Lexicon Pharmaceuticals, Inc. Key Recent Developments

May 10, 2016: Praveen Tyle, Ph.d. Joins Lexicon as Executive Vice President of Research and Development
May 03, 2016: Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 First Quarter Financial Results
Nov 06, 2015: Lexicon Pharmaceuticals Reports 3rd Quarter Financial Results And Discusses Collaboration With Sanofi For Sotagliflozin
Aug 07, 2015: Lexicon Pharmaceuticals Reports 2nd Quarter Financial Results, Provides Clinical Pipeline Update
Apr 29, 2015: Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2015 First Quarter Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Lexicon Pharmaceuticals, Inc. - Key Facts
Lexicon Pharmaceuticals, Inc. - Key Employees
Lexicon Pharmaceuticals, Inc. - Key Employee Biographies
Lexicon Pharmaceuticals, Inc. - Major Products and Services
Lexicon Pharmaceuticals, Inc. - Pharmaceutical Pipeline Products Data
Lexicon Pharmaceuticals, Inc., Pipeline Products by Therapy Area
Lexicon Pharmaceuticals, Inc., Pipeline Products by Development Phase
Lexicon Pharmaceuticals, Inc. - History
Lexicon Pharmaceuticals, Inc. - Company Statement
Lexicon Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Lexicon Pharmaceuticals, Inc. - Business Description
Lexicon Pharmaceuticals, Inc. - Corporate Strategy
Lexicon Pharmaceuticals, Inc. - SWOT Analysis
SWOT Analysis - Overview
Lexicon Pharmaceuticals, Inc. - Strengths
Strength - Patented Technologies
Strength - Focused Research and Development Activities
Strength - Strategic Alliances
Lexicon Pharmaceuticals, Inc. - Weaknesses
Weakness - Lack of Product Based Revenues
Weakness - Product Discontinuations
Lexicon Pharmaceuticals, Inc. - Opportunities
Opportunity - Orphan Drug Designation
Opportunity - Strong Product Pipeline
Opportunity - Changing Demographics
Lexicon Pharmaceuticals, Inc. - Threats
Threat - Uncertain R&D Outcomes
Threat - Competitive Pressures
Threat - Industry Regulations
Lexicon Pharmaceuticals, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Lexicon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Lexicon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Lexicon Pharmaceuticals, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 10, 2016: Praveen Tyle, Ph.d. Joins Lexicon as Executive Vice President of Research and Development
May 03, 2016: Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 First Quarter Financial Results
Nov 06, 2015: Lexicon Pharmaceuticals Reports 3rd Quarter Financial Results And Discusses Collaboration With Sanofi For Sotagliflozin
Aug 07, 2015: Lexicon Pharmaceuticals Reports 2nd Quarter Financial Results, Provides Clinical Pipeline Update
Apr 29, 2015: Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2015 First Quarter Financial Results
Apr 15, 2015: Lexicon Pharmaceuticals and Bristol-Myers Squibb Select Development Candidate for Neuropathic Pain in Neuroscience Drug Discovery and Development Alliance
Mar 04, 2015: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2014 Fourth Quarter and Full Year Financial Results
Feb 23, 2015: Lexicon Announces Management Change

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Lexicon Pharmaceuticals, Inc., Key Facts
Lexicon Pharmaceuticals, Inc., Key Employees
Lexicon Pharmaceuticals, Inc., Key Employee Biographies
Lexicon Pharmaceuticals, Inc., Major Products and Services
Lexicon Pharmaceuticals, Inc., Number of Pipeline Products by Therapy Area
Lexicon Pharmaceuticals, Inc., Number of Pipeline Products by Development Stage
Lexicon Pharmaceuticals, Inc., Pipeline Products By Therapy Area and Development Phase
Lexicon Pharmaceuticals, Inc., History
Lexicon Pharmaceuticals, Inc., Subsidiaries
Lexicon Pharmaceuticals, Inc., Key Competitors
Lexicon Pharmaceuticals, Inc., Ratios based on current share price
Lexicon Pharmaceuticals, Inc., Annual Ratios
Lexicon Pharmaceuticals, Inc., Interim Ratios
Lexicon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Lexicon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Lexicon Pharmaceuticals, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Lexicon Pharmaceuticals, Inc., Pipeline Products by Therapy Area
Lexicon Pharmaceuticals, Inc., Pipeline Products by Development Phase
Lexicon Pharmaceuticals, Inc., Performance Chart (2011 - 2015)
Lexicon Pharmaceuticals, Inc., Ratio Charts
Lexicon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Lexicon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Natural Health Trends Corp
Dyax Corp.
Acorda Therapeutics, Inc.
QLT Inc.
Geron Corporation
Skip to top


Ask Your Question

Lexicon Pharmaceuticals, Inc. (LXRX) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: